Stay updated on Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.

Latest updates to the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page
- CheckyesterdayChange DetectedThe page adds a recruitment notice 'No longer looking for participants' and introduces new help sections (How to Read a Study Record, Common Questions, How to Join a Study). It also standardizes the Intervention/Treatment header and updates revision notes from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check8 days agoChange DetectedRevision tag on the page changed from v3.5.4 to v3.5.5, reflecting a minor update to the page version.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a new revision entry v3.5.4 and removed the prior entry v3.5.3 from the page's revision history.SummaryDifference0.0%

- Check37 days agoChange DetectedThe Taiwan site entry changed from Taoyuan, Taiwan, 33305 to Taoyuan City, Taiwan, 33305. This clarifies the exact city designation for that study site.SummaryDifference0.0%

- Check51 days agoChange DetectedUpdated the ClinicalTrials.gov page revision/version number from “v3.5.2” to “v3.5.3,” reflecting a site update rather than a change to the study’s details.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.5.2.SummaryDifference0.0%

Stay in the know with updates to Dupilumab in Bullous Pemphigoid Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Bullous Pemphigoid Adults Clinical Trial page.